Quinine Quinine Quinine is a medication used to treat malaria and babesiosis. This includes the treatment of malaria due to "Plasmodium falciparum" that is resistant to chloroquine when artesunate is not available. While used for restless legs syndrome, it is not recommended for this purpose due to the risk of side effects. It can be taken by mouth or used intravenously. Malaria resistance to quinine occurs in certain areas of the world. Quinine is also the ingredient in tonic water that gives it its bitter taste. Common side effects include headache, ringing in the ears, trouble seeing, and sweating. More severe
Malaria vaccine Malaria vaccine Malaria vaccine is a vaccine that is used to prevent malaria. The only approved vaccine as of 2015 is RTS,S. It requires four injections, and has a relatively low efficacy. Due to this low efficacy, WHO does not recommend the use of RTS,S vaccine in babies between 6 and 12 weeks of age. The vaccine is going to be studied further in Africa in 2018. Research continues into recombinant protein and attenuated whole organism vaccines. RTS,S (developed by PATH Malaria Vaccine Initiative (MVI) and GlaxoSmithKline (GSK) with support from the Bill and Melinda Gates Foundation) is the most